Abstract 5994: INX-315, a potent and selective CDK2 inhibitor, demonstrates robust antitumor activity in <i>CCNE1</i>-amplified cancers

Authors: Alec G. Trub, John E. Bisi, Catherine Dietrich, Michael Taylor, Jay C. Strum, Shom Goel, Patrick J. Roberts

Published: 2023-04-04

DOI: 10.1158/1538-7445.am2023-5994

Source: Full article